サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1518856

個人用防護ガウン市場：世界の産業分析、規模、シェア、成長、動向、2024-2033年の予測

Personal Protective Gowns Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2033

出版日
ページ情報
英文 250 Pages
納期
2～5営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=143.57円
個人用防護ガウン市場：世界の産業分析、規模、シェア、成長、動向、2024-2033年の予測
出版日: 2024年07月17日
発行: Persistence Market Research
ページ情報: 英文 250 Pages
納期: 2～5営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

Persistence Market Research社はこのほど、個人用防護ガウンの世界市場に関する包括的なレポートを発表しました。当レポートでは、市場促進要因・動向・機会・課題を網羅した重要な市場ダイナミクスを幅広く評価し、市場状況に関する詳細な洞察を提供しています。

主な洞察個人用防護ガウン市場

  • 市場規模（2024年）：84億米ドル
  • 予測市場価値（2033年）：108億米ドル
  • 世界市場成長率（CAGR 2024～2033年）：2.8%

個人用防護ガウン市場- レポート範囲：

個人用防護ガウンは、感染症、化学物質、その他の危険から身を守るヘルスケア現場で重要な役割を果たしています。これらのガウンは、病院、診療所、研究所、製薬産業において不可欠であり、流体抵抗や粒子ろ過を含む様々なレベルのバリア保護を提供します。

市場促進要因：

世界の個人用防護ガウン市場は、感染防止に対する意識の高まり、ヘルスケア環境における保護具を義務付ける厳しい規制基準、世界の医療費の増加など、いくつかの主要な要因によって牽引されています。通気性生地や人間工学に基づいたデザインなど、ガウン素材の技術的進歩が快適性と安全性を高め、市場の成長を後押ししています。さらに、COVID-19の大流行により、個人防護具（PPE）の重要性が強調され、ヘルスケアおよび産業部門全体で防護衣の需要を煽っています。

市場抑制要因：

堅調な成長が見込まれるもの、個人用防護ガウン市場は、サプライチェーンの混乱、原材料コストの変動、規制遵守の複雑さに関連する課題に直面しています。PPEの製造と使用を規定する厳しい規制の枠組みは、市場関係者にコンプライアンス上の負担を課し、業務効率と市場浸透に影響を与えています。さらに、新興国地域の経済的制約が高度な防護衣技術の普及を妨げており、市場拡大の障壁となっています。

市場機会：

個人用防護ガウン市場は、技術革新、ヘルスケアインフラ投資の増加、世界の感染管理対策の拡大により、大きな成長機会をもたらしています。新しいガウンの素材やデザインの承認プロセスを合理化するために、業界利害関係者と規制機関が協力することで、市場参入が促進され、技術革新が促進されます。さらに、IoT対応モニタリングシステムやスマートファブリックなどのデジタルヘルス技術の統合により、ガウンの性能や使い勝手が向上し、市場成長の新たな道が開かれます。

本レポートで扱う主な質問

  • 個人用防護ガウン市場の世界の成長を促進している要因は何か？
  • どのガウンの素材と技術が様々なエンドユーザー分野での採用を促進しているのか？
  • 規制基準や技術の進歩は個人用防護ガウン市場の競合情勢をどのように形成しているか？
  • 個人用防護ガウン市場に貢献している主要プレイヤーは誰で、市場のリーダーシップを維持するためにどのような戦略を採用しているのか？
  • 世界の個人用防護ガウン市場の新たな動向と将来性は？

目次

第1章 エグゼクティブサマリー

第2章 市場概要

  • 市場範囲/ 分類
  • 市場の定義/ 範囲/ 制限
  • 包含と除外

第3章 主要な市場動向

  • 市場に影響を与える主な動向
  • 製品イノベーション/開発動向

第4章 重要成功要因

  • メーカーの主なプロモーション戦略
  • 規制状況
  • バリューチェーン分析
  • 製品採用分析
  • PESTEL分析
  • ポーターの分析

第5章 市場背景

  • マクロ経済要因
  • 予測要因- 関連性と影響
  • 市場力学

第6章 COVID19危機分析

  • COVID19と影響分析
    • 製品別
    • 用途別
    • エンドユーザー別
    • 国別
  • 2024年の市場シナリオ

第7章 世界市場分析（数量）

  • 過去の市場（数量）分析、2019～2023年
  • 現在および将来の市場（数量）予測、2024～2033年
    • 前年比成長動向分析

第8章 世界市場- 価格分析

  • 製品別の地域別価格分析
  • 価格の内訳
    • メーカーレベルの価格設定
    • ディストリビューターレベルの価格設定
  • 世界平均価格分析ベンチマーク

第9章 世界市場の需要（金額）分析

  • 過去の市場（金額）分析、2019～2023年
  • 現在および将来の市場（金額）予測、2024～2033年
    • 前年比成長動向分析
    • 絶対的収益機会

第10章 世界市場分析：製品別

  • イントロダクション/主な調査結果
  • 過去の市場規模（金額・数量）分析、2019～2023年
  • 現在および将来の市場規模（金額・数量）分析と予測、2024～2033年
    • 手術用ガウン
    • 隔離ガウン
    • 外科用隔離ガウン
    • 非手術用ガウン
    • 手術用ガウン
    • 手術室用ガウン
    • その他
  • 製品別市場の魅力分析

第11章 世界市場分析：用途別

  • イントロダクション/主な調査結果
  • 過去の市場規模（金額・数量）分析、2019～2023年
  • 現在および将来の市場規模（金額・数量）分析と予測、2024～2033年
    • シングル/使い捨て
    • 複数/非使い捨て
  • 用途別の市場の魅力分析

第12章 世界市場分析：エンドユーザー別

  • イントロダクション/主な調査結果
  • 過去の市場規模（金額）分析、2019～2023年
  • 現在および将来の市場規模（金額）分析と予測、2024～2033年
    • ヘルスケアセンター
    • 専門クリニック
    • その他
  • エンドユーザー別市場の魅力分析

第13章 世界市場分析：地域別

  • イントロダクション
  • 過去の市場規模（金額・数量）分析、2019～2023年
  • 現在および将来の市場規模（金額・数量）分析と予測、2024～2033年
    • 北米
    • ラテンアメリカ
    • 欧州
    • 東アジア
    • 南アジア
    • オセアニア
    • 中東およびアフリカ（中東・アフリカ）
  • 地域別市場の魅力分析

第14章 北米市場分析

第15章 ラテンアメリカ市場分析

第16章 欧州市場分析

第17章 東アジア市場分析

第18章 南アジア市場分析

第19章 オセアニア市場分析

第20章 中東・アフリカ（中東・アフリカ）市場分析

第21章 市場構造分析

  • 企業階層別市場分析
  • 主要企業の市場シェア分析
  • 市場プレゼンス分析

第22章 競合分析

  • 競合ダッシュボード
  • 競合ベンチマーク
  • 競合の詳細
    • Guangzhou Youte Plastic Products Co. Ltd.
    • Narang Medical Limited.
    • Xiangli Caps &Bags Factory Manufacturer
    • Microbiome &Genetic Testing Organisation
    • GLA Family
    • Cardinal Health
    • Novolex
    • Mediklin Healthcare Limited.
    • Radiance Inc.
    • National Safety Apparel
    • Cardinal Health
    • 3M
    • Angelica
    • Standard Textile Co
    • Medline Industries Inc
    • Aspen Surgical Products
    • Aramark
    • Priontex

第23章 使用される前提条件と頭字語

第24章 調査手法

目次
Product Code: PMRREP33336

Persistence Market Research has recently released a comprehensive report on the global market for personal protective gowns. The report provides an extensive evaluation of critical market dynamics, encompassing drivers, trends, opportunities, and challenges, offering detailed insights into the market landscape.

Key Insights: Personal Protective Gowns Market

  • Market Size (2024E): USD 8.4 Billion
  • Projected Market Value (2033F): USD 10.8 Billion
  • Global Market Growth Rate (CAGR 2024 to 2033): 2.8%

Personal Protective Gowns Market - Report Scope:

Personal protective gowns play a pivotal role in healthcare settings, offering protection against infectious diseases, chemicals, and other hazards. These gowns are essential in hospitals, clinics, laboratories, and pharmaceutical industries, providing various levels of barrier protection, including fluid resistance and particle filtration.

Market Growth Drivers:

The global personal protective gowns market is driven by several key factors, including increasing awareness of infection control practices, stringent regulatory standards mandating protective equipment in healthcare settings, and rising healthcare expenditure worldwide. Technological advancements in gown materials, such as breathable fabrics and ergonomic designs, enhance comfort and safety, thereby bolstering market growth. Moreover, the COVID-19 pandemic has underscored the importance of personal protective equipment (PPE), fueling demand for protective gowns across healthcare and industrial sectors.

Market Restraints:

Despite robust growth prospects, the personal protective gowns market faces challenges related to supply chain disruptions, fluctuating raw material costs, and regulatory compliance complexities. Stringent regulatory frameworks governing PPE manufacturing and usage impose compliance burdens on market players, affecting operational efficiencies and market penetration. Additionally, economic constraints in developing regions hinder widespread adoption of advanced protective gown technologies, presenting barriers to market expansion.

Market Opportunities:

The personal protective gowns market presents significant growth opportunities driven by technological innovations, increasing healthcare infrastructure investments, and the expansion of infection control measures globally. Collaborations between industry stakeholders and regulatory bodies to streamline approval processes for new gown materials and designs facilitate market entry and foster innovation. Furthermore, the integration of digital health technologies, such as IoT-enabled monitoring systems and smart fabrics, enhances gown performance and usability, opening new avenues for market growth.

Key Questions Answered in the Report:

  • What factors are propelling the growth of the personal protective gowns market globally?
  • Which gown materials and technologies are driving adoption across different end-user sectors?
  • How are regulatory standards and technological advancements shaping the competitive landscape of the personal protective gowns market?
  • Who are the key players contributing to the personal protective gowns market, and what strategies are they employing to maintain market leadership?
  • What are the emerging trends and future prospects in the global personal protective gowns market?

Competitive Intelligence and Business Strategy:

Leading players in the global personal protective gowns market, including DuPont de Nemours, Inc., Kimberly-Clark Corporation, and Honeywell International Inc., focus on product innovation, strategic partnerships, and geographical expansion to gain a competitive edge. These companies invest in R&D to develop advanced gown materials with enhanced durability, breathability, and protection levels, catering to diverse end-user requirements and regulatory standards. Collaboration with healthcare providers, government agencies, and industry associations facilitates market access and promotes best practices in infection prevention and control.

Key Companies Profiled:

  • Guangzhou Youte Plastic Products Co. Ltd.
  • Narang Medical Limited.
  • Xiangli Caps & Bags Factory Manufacturer
  • Microbiome & Genetic Testing Organization
  • GLA Family
  • Cardinal Health
  • Novolex
  • Mediklin Healthcare Limited.
  • Radiance Inc.
  • National Safety Apparel
  • Cardinal Health
  • 3M
  • Angelica
  • Standard Textile Co
  • Medline Industries Inc
  • Aspen Surgical Products
  • Aramark
  • Priontex

Personal Protective Gowns Industry Research Segments

By Product:

  • Surgical Gowns
  • Isolation Gowns
  • Surgical Isolation Gowns
  • Nonsurgical Gowns
  • Procedural Gowns
  • Operating Room Gowns

By Usage:

  • Single/Disposable Gowns
  • Multiple/Non-Disposable Gowns

By End User:

  • Hospitals
  • Specialty Clinics

By Region:

  • North America Market
  • Latin America Market
  • Europe Market
  • South Asia Market
  • East Asia Market
  • Oceania Market
  • Middle East and Africa (MEA) Market

Table of Contents

1. Executive Summary

  • 1.1. Global Market Outlook
  • 1.2. Demand Side Trends
  • 1.3. Supply Side Trends
  • 1.4. Analysis and Recommendations

2. Market Overview

  • 2.1. Market Coverage / Taxonomy
  • 2.2. Market Definition / Scope / Limitations
  • 2.3. Inclusions and Exclusions

3. Key Market Trends

  • 3.1. Key Trends Impacting the Market
  • 3.2. Product Innovation / Development Trends

4. Key Success Factors

  • 4.1. Key promotional strategies by manufacturers
  • 4.2. Regulatory Landscape
  • 4.3. Value chain analysis
  • 4.4. Product adoption analysis
  • 4.5. PESTEL Analysis
  • 4.6. Porter's Analysis

5. Market Background

  • 5.1. Macro-Economic Factors
    • 5.1.1. Global GDP Growth Outlook
    • 5.1.2. Global Healthcare Outlook
    • 5.1.3. Global Personal Protective Clothing Market Overview
  • 5.2. Forecast Factors - Relevance & Impact
    • 5.2.1. Increasing Demand Due to COVID-19 Pandemic
    • 5.2.2. Increasing Hospital Admissions
    • 5.2.3. Growing Awareness About Personal Safety
    • 5.2.4. Rising Incidence of Chronic and Infectious Diseases
    • 5.2.5. Growing Rates of Hospital Acquired Infections
    • 5.2.6. Rising Concerns on Medical Waste Disposal
    • 5.2.7. Regulatory Approvals and New Product Launch
  • 5.3. Market Dynamics
    • 5.3.1. Drivers
    • 5.3.2. Restraints
    • 5.3.3. Opportunity Analysis

6. COVID19 Crisis Analysis

  • 6.1. COVID19 and Impact Analysis
    • 6.1.1. By Product
    • 6.1.2. By Usage
    • 6.1.3. By End User
    • 6.1.4. By Country
  • 6.2. 2024 Market Scenario

7. Global Market Volume (Units) Analysis 2019-2023 and Forecast, 2024-2033

  • 7.1. Historical Market Volume (Units) Analysis, 2019-2023
  • 7.2. Current and Future Market Volume (Units) Projections, 2024-2033
    • 7.2.1. Y-o-Y Growth Trend Analysis

8. Global Market - Pricing Analysis

  • 8.1. Regional Pricing Analysis By Products
  • 8.2. Pricing Break-up
    • 8.2.1. Manufacturer Level Pricing
    • 8.2.2. Distributor Level Pricing
  • 8.3. Global Average Pricing Analysis Benchmark

9. Global Market Demand (in Value or Size in US$ Bn) Analysis 2019-2023 and Forecast, 2024-2033

  • 9.1. Historical Market Value (US$ Bn) Analysis, 2019-2023
  • 9.2. Current and Future Market Value (US$ Bn) Projections, 2024-2033
    • 9.2.1. Y-o-Y Growth Trend Analysis
    • 9.2.2. Absolute $ Opportunity Analysis

10. Global Market Analysis 2019-2023 and Forecast 2024-2033, By Product

  • 10.1. Introduction / Key Findings
  • 10.2. Historical Market Size (US$ Bn) and Volume (Units) Analysis By Product, 2019-2023
  • 10.3. Current and Future Market Size (US$ Bn) and Volume (Units) Analysis and Forecast By Product, 2024-2033
    • 10.3.1. Surgical Gowns
    • 10.3.2. Isolation Gowns
    • 10.3.3. Surgical Isolation Gowns
    • 10.3.4. Nonsurgical Gowns
    • 10.3.5. Procedural Gowns
    • 10.3.6. Operating Room Gowns
    • 10.3.7. Others
  • 10.4. Market Attractiveness Analysis By Product

11. Global Market Analysis 2019-2023 and Forecast 2024-2033, By Usage

  • 11.1. Introduction / Key Findings
  • 11.2. Historical Market Size (US$ Bn) Analysis, By Usage, 2019-2023
  • 11.3. Current and Future Market Size (US$ Bn) Analysis and Forecast By Usage, 2024-2033
    • 11.3.1. Single/Disposable
    • 11.3.2. Multiple/Non-Disposable
  • 11.4. Market Attractiveness Analysis By Usage

12. Global Market Analysis 2019-2023 and Forecast 2024-2033, By End User

  • 12.1. Introduction / Key Findings
  • 12.2. Historical Market Size (US$ Bn) Analysis, By End User, 2019-2023
  • 12.3. Current and Future Market Size (US$ Bn) Analysis Forecast By End User, 2024-2033
    • 12.3.1. Healthcare centers
    • 12.3.2. Specialty Clinics
    • 12.3.3. Others
  • 12.4. Market Attractiveness Analysis By End User

13. Global Market Analysis 2019-2023 and Forecast 2024-2033, By Region

  • 13.1. Introduction
  • 13.2. Historical Market Size (US$ Bn) and Volume (Units) Analysis By Region, 2019-2023
  • 13.3. Current and Future Market Value (US$ Bn) and Volume (Units) Projections, 2024-2033
    • 13.3.1. North America
    • 13.3.2. Latin America
    • 13.3.3. Europe
    • 13.3.4. East Asia
    • 13.3.5. South Asia
    • 13.3.6. Oceania
    • 13.3.7. Middle East and Africa (MEA)
  • 13.4. Market Attractiveness Analysis By Region

14. North America Market Analysis 2019-2023 and Forecast 2024-2033

  • 14.1. Introduction
  • 14.2. Historical Market Size (US$ Bn) and Volume (Unit) Analysis Trend Analysis By Market Taxonomy, 2019-2023
  • 14.3. Current and Future Market Value (US$ Bn) and Volume (Unit) Projections, 2024-2033
    • 14.3.1. By Country
      • 14.3.1.1. U.S.
      • 14.3.1.2. Canada
    • 14.3.2. By Product
    • 14.3.3. By Usage
    • 14.3.4. By End User
  • 14.4. Market Attractiveness Analysis
    • 14.4.1. By Country
    • 14.4.2. By Product
    • 14.4.3. By Usage
    • 14.4.4. By End User
  • 14.5. Market Trends
  • 14.6. Drivers and Restraints - Impact Analysis
  • 14.7. Country Level Analysis & Forecast
    • 14.7.1. U.S. Market Analysis
      • 14.7.1.1. Introduction
      • 14.7.1.2. Market Analysis and Forecast by Market Taxonomy
        • 14.7.1.2.1. By Product
        • 14.7.1.2.2. By Usage
        • 14.7.1.2.3. By End User
    • 14.7.2. Canada Market Analysis
      • 14.7.2.1. Introduction
      • 14.7.2.2. Market Analysis and Forecast by Market Taxonomy
        • 14.7.2.2.1. By Product
        • 14.7.2.2.2. By Usage
        • 14.7.2.2.3. By End User

15. Latin America Market Analysis 2019-2023 and Forecast 2024-2033

  • 15.1. Introduction
  • 15.2. Historical Market Size (US$ Bn) and Volume (Unit) Analysis Trend Analysis By Market Taxonomy, 2019-2023
  • 15.3. Current and Future Market Value (US$ Bn) and Volume (Unit) Projections, 2024-2033
    • 15.3.1. By Country
      • 15.3.1.1. Mexico
      • 15.3.1.2. Brazil
      • 15.3.1.3. Argentina
      • 15.3.1.4. Rest of Latin America
    • 15.3.2. By Product
    • 15.3.3. By Usage
    • 15.3.4. By End User
  • 15.4. Market Attractiveness Analysis
    • 15.4.1. By Country
    • 15.4.2. By Product
    • 15.4.3. By Usage
    • 15.4.4. By End User
  • 15.5. Market Trends
  • 15.6. Drivers and Restraints - Impact Analysis
  • 15.7. Country Level Analysis & Forecast
    • 15.7.1. Mexico Market Analysis
      • 15.7.1.1. Introduction
      • 15.7.1.2. Market Analysis and Forecast by Market Taxonomy
        • 15.7.1.2.1. By Product
        • 15.7.1.2.2. By Usage
        • 15.7.1.2.3. By End User
    • 15.7.2. Brazil Market Analysis
      • 15.7.2.1. Introduction
      • 15.7.2.2. Market Analysis and Forecast by Market Taxonomy
        • 15.7.2.2.1. By Product
        • 15.7.2.2.2. By Usage
        • 15.7.2.2.3. By End User
    • 15.7.3. Argentina Market Analysis
      • 15.7.3.1. Introduction
      • 15.7.3.2. Market Analysis and Forecast by Market Taxonomy
        • 15.7.3.2.1. By Product
        • 15.7.3.2.2. By Usage
        • 15.7.3.2.3. By End User

16. Europe Market Analysis 2019-2023 and Forecast 2024-2033

  • 16.1. Introduction
  • 16.2. Historical Market Size (US$ Bn) and Volume (Unit) Analysis Trend Analysis By Market Taxonomy, 2019-2023
  • 16.3. Current and Future Market Value (US$ Bn) and Volume (Unit) Projections, 2024-2033
    • 16.3.1. By Country
      • 16.3.1.1. Germany
      • 16.3.1.2. Italy
      • 16.3.1.3. France
      • 16.3.1.4. U.K.
      • 16.3.1.5. Spain
      • 16.3.1.6. BENELUX
      • 16.3.1.7. Russia
      • 16.3.1.8. Rest of Europe
    • 16.3.2. By Product
    • 16.3.3. By Usage
    • 16.3.4. By End User
  • 16.4. Market Attractiveness Analysis
    • 16.4.1. By Country
    • 16.4.2. By Product
    • 16.4.3. By Usage
    • 16.4.4. By End User
  • 16.5. Market Trends
  • 16.6. Drivers and Restraints - Impact Analysis
  • 16.7. Country Level Analysis & Forecast
    • 16.7.1. Germany Market Analysis
      • 16.7.1.1. Introduction
      • 16.7.1.2. Market Analysis and Forecast by Market Taxonomy
        • 16.7.1.2.1. By Product
        • 16.7.1.2.2. By Usage
        • 16.7.1.2.3. By End User
    • 16.7.2. Italy Market Analysis
      • 16.7.2.1. Introduction
      • 16.7.2.2. Market Analysis and Forecast by Market Taxonomy
        • 16.7.2.2.1. By Product
        • 16.7.2.2.2. By Usage
        • 16.7.2.2.3. By End User
    • 16.7.3. France Market Analysis
      • 16.7.3.1. Introduction
      • 16.7.3.2. Market Analysis and Forecast by Market Taxonomy
        • 16.7.3.2.1. By Product
        • 16.7.3.2.2. By Usage
        • 16.7.3.2.3. By End User
    • 16.7.4. U.K. Market Analysis
      • 16.7.4.1. Introduction
      • 16.7.4.2. Market Analysis and Forecast by Market Taxonomy
        • 16.7.4.2.1. By Product
        • 16.7.4.2.2. By Usage
        • 16.7.4.2.3. By End User
    • 16.7.5. Spain Market Analysis
      • 16.7.5.1. Introduction
      • 16.7.5.2. Market Analysis and Forecast by Market Taxonomy
        • 16.7.5.2.1. By Product
        • 16.7.5.2.2. By Usage
        • 16.7.5.2.3. By End User
    • 16.7.6. BENELUX Market Analysis
      • 16.7.6.1. Introduction
      • 16.7.6.2. Market Analysis and Forecast by Market Taxonomy
        • 16.7.6.2.1. By Product
        • 16.7.6.2.2. By Usage
        • 16.7.6.2.3. By End User
    • 16.7.7. Russia Market Analysis
      • 16.7.7.1. Introduction
      • 16.7.7.2. Market Analysis and Forecast by Market Taxonomy
        • 16.7.7.2.1. By Product
        • 16.7.7.2.2. By Usage
        • 16.7.7.2.3. By End User

17. East Asia Market Analysis 2019-2023 and Forecast 2024-2033

  • 17.1. Introduction
  • 17.2. Historical Market Size (US$ Bn) and Volume (Unit) Analysis Trend Analysis By Market Taxonomy, 2019-2023
  • 17.3. Current and Future Market Value (US$ Bn) and Volume (Unit) Projections, 2024-2033
    • 17.3.1. By Country
      • 17.3.1.1. China
      • 17.3.1.2. Japan
      • 17.3.1.3. South Korea
    • 17.3.2. By Product
    • 17.3.3. By Usage
    • 17.3.4. By End User
  • 17.4. Market Attractiveness Analysis
    • 17.4.1. By Country
    • 17.4.2. By Product
    • 17.4.3. By Usage
    • 17.4.4. By End User
  • 17.5. Market Trends
  • 17.6. Drivers and Restraints - Impact Analysis
  • 17.7. Country Level Analysis & Forecast
    • 17.7.1. China Market Analysis
      • 17.7.1.1. Introduction
      • 17.7.1.2. Market Analysis and Forecast by Market Taxonomy
        • 17.7.1.2.1. By Product
        • 17.7.1.2.2. By Usage
        • 17.7.1.2.3. By End User
    • 17.7.2. Japan Market Analysis
      • 17.7.2.1. Introduction
      • 17.7.2.2. Market Analysis and Forecast by Market Taxonomy
        • 17.7.2.2.1. By Product
        • 17.7.2.2.2. By Usage
        • 17.7.2.2.3. By End User
    • 17.7.3. South Korea Market Analysis
      • 17.7.3.1. Introduction
      • 17.7.3.2. Market Analysis and Forecast by Market Taxonomy
        • 17.7.3.2.1. By Product
        • 17.7.3.2.2. By Usage
        • 17.7.3.2.3. By End User

18. South Asia Market Analysis 2019-2023 and Forecast 2024-2033

  • 18.1. Introduction
  • 18.2. Historical Market Size (US$ Bn) and Volume (Unit) Analysis Trend Analysis By Market Taxonomy, 2019-2023
  • 18.3. Current and Future Market Value (US$ Bn) and Volume (Unit) Projections, 2024-2033
    • 18.3.1. By Country
      • 18.3.1.1. India
      • 18.3.1.2. Indonesia
      • 18.3.1.3. Malaysia
      • 18.3.1.4. Thailand
      • 18.3.1.5. Rest of South Asia
    • 18.3.2. By Product
    • 18.3.3. By Usage
    • 18.3.4. By End User
  • 18.4. Market Attractiveness Analysis
    • 18.4.1. By Country
    • 18.4.2. By Product
    • 18.4.3. By Usage
    • 18.4.4. By End User
  • 18.5. Market Trends
  • 18.6. Drivers and Restraints - Impact Analysis
  • 18.7. Country Level Analysis & Forecast
    • 18.7.1. India Market Analysis
      • 18.7.1.1. Introduction
      • 18.7.1.2. Market Analysis and Forecast by Market Taxonomy
        • 18.7.1.2.1. By Product
        • 18.7.1.2.2. By Usage
        • 18.7.1.2.3. By End User
    • 18.7.2. Indonesia Market Analysis
      • 18.7.2.1. Introduction
      • 18.7.2.2. Market Analysis and Forecast by Market Taxonomy
        • 18.7.2.2.1. By Product
        • 18.7.2.2.2. By Usage
        • 18.7.2.2.3. By End User
    • 18.7.3. Malaysia Market Analysis
      • 18.7.3.1. Introduction
      • 18.7.3.2. Market Analysis and Forecast by Market Taxonomy
        • 18.7.3.2.1. By Product
        • 18.7.3.2.2. By Usage
        • 18.7.3.2.3. By End User
    • 18.7.4. Thailand Market Analysis
      • 18.7.4.1. Introduction
      • 18.7.4.2. Market Analysis and Forecast by Market Taxonomy
        • 18.7.4.2.1. By Product
        • 18.7.4.2.2. By Usage
        • 18.7.4.2.3. By End User

19. Oceania Market Analysis 2019-2023 and Forecast 2024-2033

  • 19.1. Introduction
  • 19.2. Historical Market Size (US$ Bn) and Volume (Unit) Analysis Trend Analysis By Market Taxonomy, 2019-2023
  • 19.3. Current and Future Market Value (US$ Bn) and Volume (Unit) Projections, 2024-2033
    • 19.3.1. By Country
      • 19.3.1.1. Australia
      • 19.3.1.2. New Zealand
    • 19.3.2. By Product
    • 19.3.3. By Usage
    • 19.3.4. By End User
  • 19.4. Market Attractiveness Analysis
    • 19.4.1. By Country
    • 19.4.2. By Product
    • 19.4.3. By Usage
    • 19.4.4. By End User
  • 19.5. Key Market Participants - Intensity Mapping
  • 19.6. Drivers and Restraints - Impact Analysis
  • 19.7. Country Level Analysis & Forecast
    • 19.7.1. Australia Market Analysis
      • 19.7.1.1. Introduction
      • 19.7.1.2. Market Analysis and Forecast by Market Taxonomy
        • 19.7.1.2.1. By Product
        • 19.7.1.2.2. By Usage
        • 19.7.1.2.3. By End User
    • 19.7.2. New Zealand Market Analysis
      • 19.7.2.1. Introduction
      • 19.7.2.2. Market Analysis and Forecast by Market Taxonomy
        • 19.7.2.2.1. By Product
        • 19.7.2.2.2. By Usage
        • 19.7.2.2.3. By End User

20. Middle East and Africa (MEA) Market Analysis 2019-2023 and Forecast 2024-2033

  • 20.1. Introduction
  • 20.2. Historical Market Size (US$ Bn) and Volume (Unit) Analysis Trend Analysis By Market Taxonomy, 2019-2023
  • 20.3. Current and Future Market Value (US$ Bn) and Volume (Unit) Projections, 2024-2033
    • 20.3.1. By Country
      • 20.3.1.1. GCC Countries
      • 20.3.1.2. Turkey
      • 20.3.1.3. South Africa
      • 20.3.1.4. Rest of Middle East and Africa
    • 20.3.2. By Product
    • 20.3.3. By Usage
    • 20.3.4. By End User
  • 20.4. Market Attractiveness Analysis
    • 20.4.1. By Country
    • 20.4.2. By Product
    • 20.4.3. By Usage
    • 20.4.4. By End User
  • 20.5. Market Trends
  • 20.6. Drivers and Restraints - Impact Analysis
  • 20.7. Country Level Analysis & Forecast
    • 20.7.1. GCC Countries Market Analysis
      • 20.7.1.1. Introduction
      • 20.7.1.2. Market Analysis and Forecast by Market Taxonomy
        • 20.7.1.2.1. By Product
        • 20.7.1.2.2. By Usage
        • 20.7.1.2.3. By End User
    • 20.7.2. Turkey Market Analysis
      • 20.7.2.1. Introduction
      • 20.7.2.2. Market Analysis and Forecast by Market Taxonomy
        • 20.7.2.2.1. By Product
        • 20.7.2.2.2. By Usage
        • 20.7.2.2.3. By End User
    • 20.7.3. South Africa Market Analysis
      • 20.7.3.1. Introduction
      • 20.7.3.2. Market Analysis and Forecast by Market Taxonomy
        • 20.7.3.2.1. By Product
        • 20.7.3.2.2. By Usage
        • 20.7.3.2.3. By End User
    • 20.7.4. North Africa Market Analysis
      • 20.7.4.1. Introduction
      • 20.7.4.2. Market Analysis and Forecast by Market Taxonomy
        • 20.7.4.2.1. By Product
        • 20.7.4.2.2. By Usage
        • 20.7.4.2.3. By End User

21. Market Structure Analysis

  • 21.1. Market Analysis by Tier of Companies
  • 21.2. Market Share Analysis of Top Players
  • 21.3. Market Presence Analysis

22. Competition Analysis

  • 22.1. Competition Dashboard
  • 22.2. Competition Benchmarking
  • 22.3. Competition Deep Dive
    • 22.3.1. Guangzhou Youte Plastic Products Co. Ltd.
      • 22.3.1.1. Overview
      • 22.3.1.2. Product Portfolio
      • 22.3.1.3. Profitability by Market Segments (Product/Channel/Region)
      • 22.3.1.4. Sales Footprint
      • 22.3.1.5. Key Financials
      • 22.3.1.6. SWOT Analysis
      • 22.3.1.7. Strategy Overview
    • 22.3.2. Narang Medical Limited.
      • 22.3.2.1. Overview
      • 22.3.2.2. Product Portfolio
      • 22.3.2.3. Profitability by Market Segments (Product/Channel/Region)
      • 22.3.2.4. Sales Footprint
      • 22.3.2.5. Key Financials
      • 22.3.2.6. SWOT Analysis
      • 22.3.2.7. Strategy Overview
    • 22.3.3. Xiangli Caps & Bags Factory Manufacturer
      • 22.3.3.1. Overview
      • 22.3.3.2. Product Portfolio
      • 22.3.3.3. Profitability by Market Segments (Product/Channel/Region)
      • 22.3.3.4. Sales Footprint
      • 22.3.3.5. Key Financials
      • 22.3.3.6. SWOT Analysis
      • 22.3.3.7. Strategy Overview
    • 22.3.4. Microbiome & Genetic Testing Organisation
      • 22.3.4.1. Overview
      • 22.3.4.2. Product Portfolio
      • 22.3.4.3. Profitability by Market Segments (Product/Channel/Region)
      • 22.3.4.4. Sales Footprint
      • 22.3.4.5. Key Financials
      • 22.3.4.6. SWOT Analysis
      • 22.3.4.7. Strategy Overview
    • 22.3.5. GLA Family
      • 22.3.5.1. Overview
      • 22.3.5.2. Product Portfolio
      • 22.3.5.3. Profitability by Market Segments (Product/Channel/Region)
      • 22.3.5.4. Sales Footprint
      • 22.3.5.5. Key Financials
      • 22.3.5.6. SWOT Analysis
      • 22.3.5.7. Strategy Overview
    • 22.3.6. Cardinal Health
      • 22.3.6.1. Overview
      • 22.3.6.2. Product Portfolio
      • 22.3.6.3. Profitability by Market Segments (Product/Channel/Region)
      • 22.3.6.4. Sales Footprint
      • 22.3.6.5. Key Financials
      • 22.3.6.6. SWOT Analysis
      • 22.3.6.7. Strategy Overview
    • 22.3.7. Novolex
      • 22.3.7.1. Overview
      • 22.3.7.2. Product Portfolio
      • 22.3.7.3. Profitability by Market Segments (Product/Channel/Region)
      • 22.3.7.4. Sales Footprint
      • 22.3.7.5. Key Financials
      • 22.3.7.6. SWOT Analysis
      • 22.3.7.7. Strategy Overview
    • 22.3.8. Mediklin Healthcare Limited.
      • 22.3.8.1. Overview
      • 22.3.8.2. Product Portfolio
      • 22.3.8.3. Profitability by Market Segments (Product/Channel/Region)
      • 22.3.8.4. Sales Footprint
      • 22.3.8.5. Key Financials
      • 22.3.8.6. SWOT Analysis
      • 22.3.8.7. Strategy Overview
    • 22.3.9. Radiance Inc.
      • 22.3.9.1. Overview
      • 22.3.9.2. Product Portfolio
      • 22.3.9.3. Profitability by Market Segments (Product/Channel/Region)
      • 22.3.9.4. Sales Footprint
      • 22.3.9.5. Key Financials
      • 22.3.9.6. SWOT Analysis
      • 22.3.9.7. Strategy Overview
    • 22.3.10. National Safety Apparel
      • 22.3.10.1. Overview
      • 22.3.10.2. Product Portfolio
      • 22.3.10.3. Profitability by Market Segments (Product/Channel/Region)
      • 22.3.10.4. Sales Footprint
      • 22.3.10.5. Key Financials
      • 22.3.10.6. SWOT Analysis
      • 22.3.10.7. Strategy Overview
    • 22.3.11. Cardinal Health
      • 22.3.11.1. Overview
      • 22.3.11.2. Product Portfolio
      • 22.3.11.3. Profitability by Market Segments (Product/Channel/Region)
      • 22.3.11.4. Sales Footprint
      • 22.3.11.5. Key Financials
      • 22.3.11.6. SWOT Analysis
      • 22.3.11.7. Strategy Overview
    • 22.3.12. 3M
      • 22.3.12.1. Overview
      • 22.3.12.2. Product Portfolio
      • 22.3.12.3. Profitability by Market Segments (Product/Channel/Region)
      • 22.3.12.4. Sales Footprint
      • 22.3.12.5. Key Financials
      • 22.3.12.6. SWOT Analysis
      • 22.3.12.7. Strategy Overview
    • 22.3.13. Angelica
      • 22.3.13.1. Overview
      • 22.3.13.2. Product Portfolio
      • 22.3.13.3. Profitability by Market Segments (Product/Channel/Region)
      • 22.3.13.4. Sales Footprint
      • 22.3.13.5. Key Financials
      • 22.3.13.6. SWOT Analysis
      • 22.3.13.7. Strategy Overview
    • 22.3.14. Standard Textile Co
      • 22.3.14.1. Overview
      • 22.3.14.2. Product Portfolio
      • 22.3.14.3. Profitability by Market Segments (Product/Channel/Region)
      • 22.3.14.4. Sales Footprint
      • 22.3.14.5. Key Financials
      • 22.3.14.6. SWOT Analysis
      • 22.3.14.7. Strategy Overview
    • 22.3.15. Medline Industries Inc
      • 22.3.15.1. Overview
      • 22.3.15.2. Product Portfolio
      • 22.3.15.3. Profitability by Market Segments (Product/Channel/Region)
      • 22.3.15.4. Sales Footprint
      • 22.3.15.5. Key Financials
      • 22.3.15.6. SWOT Analysis
      • 22.3.15.7. Strategy Overview
    • 22.3.16. Aspen Surgical Products
      • 22.3.16.1. Overview
      • 22.3.16.2. Product Portfolio
      • 22.3.16.3. Profitability by Market Segments (Product/Channel/Region)
      • 22.3.16.4. Sales Footprint
      • 22.3.16.5. Key Financials
      • 22.3.16.6. SWOT Analysis
      • 22.3.16.7. Strategy Overview
    • 22.3.17. Aramark
      • 22.3.17.1. Overview
      • 22.3.17.2. Product Portfolio
      • 22.3.17.3. Profitability by Market Segments (Product/Channel/Region)
      • 22.3.17.4. Sales Footprint
      • 22.3.17.5. Key Financials
      • 22.3.17.6. SWOT Analysis
      • 22.3.17.7. Strategy Overview
    • 22.3.18. Priontex
      • 22.3.18.1. Overview
      • 22.3.18.2. Product Portfolio
      • 22.3.18.3. Profitability by Market Segments (Product/Channel/Region)
      • 22.3.18.4. Sales Footprint
      • 22.3.18.5. Key Financials
      • 22.3.18.6. SWOT Analysis
      • 22.3.18.7. Strategy Overview

23. Assumptions and Acronyms Used

24. Research Methodology